Beta Bionics, an Irvine, CA-based firm which specializes within the growth of superior diabetes administration options, raised $60M in Collection E funding.
The spherical was led by Wellington Administration. Earlier buyers Eventide Asset Administration LLC, sure funds managed by RTW Investments, Sands Capital, Soleus Capital, Omega Funds, Perceptive Advisors, and Marshall Wace additionally participated.
The corporate intends to make use of the funds to help expanded commercialization of the iLet Bionic Pancreas and develop the product pipeline.
Led Beta Bionics is a diabetes administration options firm offering the iLet Bionic Pancreas, which is an autonomous insulin supply system that streamlines diabetes administration and reduces the burden on sufferers, caregivers and physicians.
FinSMEs
15/11/2024
